<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04042246</url>
  </required_header>
  <id_info>
    <org_study_id>TBDNA</org_study_id>
    <nct_id>NCT04042246</nct_id>
  </id_info>
  <brief_title>Effect of Knowledge on Vaccine Take-up in Adamawa State, Northeastern Nigeria</brief_title>
  <official_title>Knowledge on Vaccination Schedule and Full Immunization, and Its Effect on Vaccine Take-up in Jada Local Government Area in Adamawa State, Northeastern Nigeria</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Harvard School of Public Health</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Harvard School of Public Health</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Child immunization is not a one-time behavior; rather, it is a repeated behavior within a
      specific timeframe. Not only the low immunization, but also the dropout of immunization and
      the delayed immunization from the recommended immunization schedule are prevalent and high in
      Africa. The most common reason for the incomplete vaccination is that caregivers thought the
      children had already been fully immunized (44.8%), according to Nigeria Multiple Indicator
      Cluster Survey (MICS) conducted in 2016/2017.

      Caregivers' misconception of the complete immunization can be attributed to the complicated
      immunization schedule. In Nigeria, infants are supposed to receive 9 different types of
      vaccines at 5 different times within the first year since the births. To make things more
      complicated, the vaccine schedule changes over time; for example in Nigeria, the new vaccine,
      inactivated polio vaccine (IPV) was introduced in 2015 to be received at 14 weeks after
      births, and rotavirus vaccine and meningococcal A vaccine are scheduled for the introduction
      in 2019.

      In this complicated and rapidly-changing environment regarding vaccination schedule, the goal
      of the study is to improve the understanding of vaccination completion and children's
      vaccination status among caregivers, which can then lead to the improved rate of full
      vaccination among children.

      Objectives The main objectives of this study are to understand the impact of providing the
      general and tailored information on the vaccination schedule and vaccination status of
      women's children on the vaccine take-up. In this study, the investigators focus on women who
      has a child who is 12 months old or younger.

      Hypothesis

      The main hypothesis of this proposed study are as follows:

        1. Information on vaccination among caregivers: the general and tailored information on
           vaccination schedule and child's vaccination status, improves the knowledge on benefit
           and understanding of vaccination completion, vaccination schedule and the vaccination
           status of the children among caregivers

        2. Full immunization rate: through the improved knowledge level on the concept of
           vaccination completion and their children's vaccination status, the proposed study
           increases the full immunization rate among children
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background and Objectives Despite the proven benefit of vaccines, the child immunization rate
      has been stagnant and the rate in African countries lags behind other regions in the world.
      For example, the global coverage of three doses diphtheria-tetanus-pertussis (DPT3) has been
      stagnant at 85% since 2015, while DPT3 coverage in Africa remains at 72% since 2010. The
      distribution of unvaccinated children is unequal; out of about 20 million infants who are not
      fully vaccinated, more than 20 percent of them reside in three countries, including Nigeria,
      the proposed study site. Furthermore, Nigeria is one of the few countries where the coverage
      of DPT3 coverage has decreased over time: 54 percent in 2010 to 42 percent in 2017.

      Child immunization is not a one-time behavior; rather, it is a repeated behavior within a
      specific timeframe. Not only the low immunization, but also the dropout of immunization and
      the delayed immunization from the recommended immunization schedule are prevalent and high in
      Africa. The most common reason for the incomplete vaccination is that caregivers thought the
      children had already been fully immunized (44.8%), according to Nigeria Multiple Indicator
      Cluster Survey (MICS) conducted in 2016/2017.

      Caregivers' misconception of the complete immunization can be attributed to the complicated
      immunization schedule. Each type and dose of vaccine has its own significance in terms of the
      type of preventable disease and the achievable efficacy level. In Nigeria, infants are
      supposed to receive 9 different types of vaccines at 5 different times within the first year
      since the births. For example, oral poliovirus vaccine (OPV) is to protect infants from
      contracting polio, a highly contagious disease. At present, Nigeria is one of the three
      countries in the world, which have not eliminated polio. Infants are scheduled to receive OPV
      four times; at birth, 6, 10, and 14 weeks. The efficacy of the first dose OPV (oral polio
      vaccine) is 82%, while the second and the third doses are 90% and 99% or more, respectively.
      To make things more complicated, the vaccine schedule changes over time; for example in
      Nigeria, the new vaccine, inactivated polio vaccine (IPV) was introduced in 2015 to be
      received at 14 weeks after births, and rotavirus vaccine and meningococcal A vaccine are
      scheduled for the introduction in 2019.

      In this complicated and rapidly-changing environment regarding vaccination schedule, the goal
      of the study is to improve the understanding of vaccination completion and children's
      vaccination status among caregivers, which can then lead to the improved rate of full
      vaccination among children.

      Objectives The main objectives of this study are to understand the impact of providing the
      general and tailored information on the vaccination schedule and vaccination status of
      women's children on the vaccine take-up. This study focuses on women who has a child who is
      12 months old or younger.

      Hypothesis

      The main hypothesis of this proposed study are as follows:

        1. Information on vaccination among caregivers: the general and tailored information on
           vaccination schedule and child's vaccination status, improves the knowledge on benefit
           and understanding of vaccination completion, vaccination schedule and the vaccination
           status of the children among caregivers

        2. Full immunization rate: through the improved knowledge level on the concept of
           vaccination completion and their children's vaccination status, the proposed study
           increases the full immunization rate among children

      Literature Review Knowledge is powerful in shaping people's health behaviors. In a situation
      where the health behaviors among the population do not reach the optimal level, one obvious
      way to attempt to improve the situation is to provide the information to encourage the
      population for adopting the health behaviors.

      In case of vaccination, information provision has a great potential to increase the take-up
      of vaccination, especially in places where one of the main perceived barriers is the lack of
      knowledge on the vaccination schedule, as is the case in Adamawa state.

      However, the effectiveness of information provision on the vaccine take-up might differ,
      depending on the type of information provided. One study provided the information on the
      benefit of tetanus vaccines to caregivers in India and they found the strong effect of the
      information provision on the vaccine take-up. The effectiveness of gain-framed and
      loss-framed messaging was statistically identical in their study. On the other hand, salient
      information, such as fear appeals, might be ineffective or it can even backfire. The
      investigators found, in the previous project, that in Jada Local Government Area, fear
      appeals intervention backfired on the tetanus-toxoid vaccine take-up among women who never
      received the vaccine.

      If caregivers are not aware of the vaccination schedule as found in MICS 2016/2017, simply
      providing the information on the next vaccination schedule can be effective. Recent
      technological advancement makes it easy and cost-effective to send the reminder through SMS
      message.

      Although SMS (Short Message Service) reminders are found to be effective in affecting
      one-time vaccine take-up, this intervention should be accompanied with the provision of more
      fundamental information, which can induce the repeated vaccination behaviors, to make the
      effect of intervention sustainable. This study proposes to provide fundamental information,
      which informs respondents the overall vaccination schedule, as well as tailored information,
      which informs where their children are in the vaccination schedule. The investigators
      hypothesize that, once respondents understand the overall vaccination schedule, it is easy to
      comprehend when and how many times more they should visit the clinic, instead of fully
      relying on the supply-side intervention such as SMS reminders.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 15, 2019</start_date>
  <completion_date type="Actual">February 9, 2020</completion_date>
  <primary_completion_date type="Actual">February 9, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of participants who have the accurate knowledge level of vaccination, as assessed by survey questionnaire</measure>
    <time_frame>2 weeks</time_frame>
    <description>The investigators will collect the information on respondents' knowledge on vaccination through surveys. The knowledge level is calculated from 5 questions: 1) the number of type of vaccines a child needs to receive before 12 months old, 2) the number of times a child needs to receive Pentavalent vaccine, 3) the last month when a child needs to receive Pentavalent vaccine, 4) the timing when a child needs to receive BCG vaccine, and 5) the number of clinic visits (at minimum) a child needs to make for complete vaccination. For each question, the score is 0 if wrong, or 1 if correct.
The knowledge level scale ranges from 0 to 5, which is the total number of correct answers.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of participants who bring their children for the full vaccination, as assessed by the follow-up tracking survey at health clinics</measure>
    <time_frame>9 months</time_frame>
    <description>The investigators will collect the information on the actual vaccination status among respondents' children</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">400</enrollment>
  <condition>Immunization; Infection</condition>
  <condition>Educational Problems</condition>
  <condition>Information Seeking Behavior</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>No intervention is implemented among Control</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Treatment (Educational Information on Vaccination)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Provide general and tailored information on vaccination and vaccination schedule at the end of the baseline survey</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Information Provision</intervention_name>
    <description>Provide the information on the importance of the vaccination and tailored vaccination schedule</description>
    <arm_group_label>Treatment (Educational Information on Vaccination)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  women with a child 12 months old or younger

        Exclusion Criteria:

          -  exclude women who do not have a child 12 months or younger
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ryoko Sato, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Harvard School of Public Health</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Jada Local Government Primary Health Care Development Agency</name>
      <address>
        <city>Jada</city>
        <state>Adamawa</state>
        <country>Nigeria</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Nigeria</country>
  </location_countries>
  <reference>
    <citation>Bolu O, Nnadi C, Damisa E, Braka F, Siddique A, Archer WR, Bammeke P, Banda R, Higgins J, Edukugo A, Nganda GW, Forbi JC, Liu H, Gidado S, Soghaier M, Franka R, Waziri N, Burns CC, Vertefeuille J, Wiesen E, Adamu U. Progress Toward Poliomyelitis Eradication - Nigeria, January-December 2017. MMWR Morb Mortal Wkly Rep. 2018 Mar 2;67(8):253-256. doi: 10.15585/mmwr.mm6708a5.</citation>
    <PMID>29494568</PMID>
  </reference>
  <reference>
    <citation>Feldstein LR, Mariat S, Gacic-Dobo M, Diallo MS, Conklin LM, Wallace AS. Global Routine Vaccination Coverage, 2016. MMWR Morb Mortal Wkly Rep. 2017 Nov 17;66(45):1252-1255. doi: 10.15585/mmwr.mm6645a3.</citation>
    <PMID>29145357</PMID>
  </reference>
  <reference>
    <citation>Kazungu JS, Adetifa IMO. Crude childhood vaccination coverage in West Africa: Trends and predictors of completeness. Wellcome Open Res. 2017 Feb 15;2:12. doi: 10.12688/wellcomeopenres.10690.1.</citation>
    <PMID>28459105</PMID>
  </reference>
  <reference>
    <citation>Kim-Farley RJ, Rutherford G, Lichfield P, Hsu ST, Orenstein WA, Schonberger LB, Bart KJ, Lui KJ, Lin CC. Outbreak of paralytic poliomyelitis, Taiwan. Lancet. 1984 Dec 8;2(8415):1322-4.</citation>
    <PMID>6150332</PMID>
  </reference>
  <reference>
    <citation>Lukusa LA, Ndze VN, Mbeye NM, Wiysonge CS. A systematic review and meta-analysis of the effects of educating parents on the benefits and schedules of childhood vaccinations in low and middle-income countries. Hum Vaccin Immunother. 2018;14(8):2058-2068. doi: 10.1080/21645515.2018.1457931. Epub 2018 May 14.</citation>
    <PMID>29580159</PMID>
  </reference>
  <reference>
    <citation>Manakongtreecheep K. SMS-reminder for vaccination in Africa: research from published, unpublished and grey literature. Pan Afr Med J. 2017 Jun 22;27(Suppl 3):23. doi: 10.11604/pamj.supp.2017.27.3.12115. eCollection 2017.</citation>
    <PMID>29296158</PMID>
  </reference>
  <reference>
    <citation>Mbengue MAS, Mboup A, Ly ID, Faye A, Camara FBN, Thiam M, Ndiaye BP, Dieye TN, Mboup S. Vaccination coverage and immunization timeliness among children aged 12-23 months in Senegal: a Kaplan-Meier and Cox regression analysis approach. Pan Afr Med J. 2017 Jun 21;27(Suppl 3):8. doi: 10.11604/pamj.supp.2017.27.3.11534. eCollection 2017.</citation>
    <PMID>29296143</PMID>
  </reference>
  <reference>
    <citation>Mutua MK, Kimani-Murage E, Ngomi N, Ravn H, Mwaniki P, Echoka E. Fully immunized child: coverage, timing and sequencing of routine immunization in an urban poor settlement in Nairobi, Kenya. Trop Med Health. 2016 May 16;44:13. doi: 10.1186/s41182-016-0013-x. eCollection 2016.</citation>
    <PMID>27433132</PMID>
  </reference>
  <reference>
    <citation>Powell-Jackson T, Fabbri C, Dutt V, Tougher S, Singh K. Effect and cost-effectiveness of educating mothers about childhood DPT vaccination on immunisation uptake, knowledge, and perceptions in Uttar Pradesh, India: A randomised controlled trial. PLoS Med. 2018 Mar 6;15(3):e1002519. doi: 10.1371/journal.pmed.1002519. eCollection 2018 Mar.</citation>
    <PMID>29509769</PMID>
  </reference>
  <reference>
    <citation>Tannenbaum MB, Hepler J, Zimmerman RS, Saul L, Jacobs S, Wilson K, Albarrac√≠n D. Appealing to fear: A meta-analysis of fear appeal effectiveness and theories. Psychol Bull. 2015 Nov;141(6):1178-204. doi: 10.1037/a0039729. Review.</citation>
    <PMID>26501228</PMID>
  </reference>
  <reference>
    <citation>VanderEnde K, Gacic-Dobo M, Diallo MS, Conklin LM, Wallace AS. Global Routine Vaccination Coverage - 2017. MMWR Morb Mortal Wkly Rep. 2018 Nov 16;67(45):1261-1264. doi: 10.15585/mmwr.mm6745a2.</citation>
    <PMID>30439873</PMID>
  </reference>
  <reference>
    <citation>Jacobson Vann JC, Jacobson RM, Coyne-Beasley T, Asafu-Adjei JK, Szilagyi PG. Patient reminder and recall interventions to improve immunization rates. Cochrane Database Syst Rev. 2018 Jan 18;1:CD003941. doi: 10.1002/14651858.CD003941.pub3. Review.</citation>
    <PMID>29342498</PMID>
  </reference>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>July 29, 2019</study_first_submitted>
  <study_first_submitted_qc>July 31, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">August 1, 2019</study_first_posted>
  <last_update_submitted>July 11, 2020</last_update_submitted>
  <last_update_submitted_qc>July 11, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 14, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Harvard School of Public Health</investigator_affiliation>
    <investigator_full_name>Ryoko Sato</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

